← Human Trials & Peer-Reviewed Studies
Determinants and Measurement of Neonatal Vitamin D: Overestimation of 25(OH)D in Cord Blood Using CLIA Assay Technology.
Plain-language guide to PMID 31872219 (2020): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 881 women.
Key Facts
- PMID
- 31872219
- Journal
- The Journal of clinical endocrinology and metabolism
- Year
- 2020
- Study type
- Randomized Controlled Trial
- Authors
- Lu M et al. (7 authors)
- DOI
- 10.1210/clinem/dgz299
- Registered trial
- NCT00920621
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.
To assess the validity of a CLIA in the measurement of cord blood 25(OH)D and to evaluate maternal determinants of neonatal 25(OH)D, including early versus late pregnancy 25(OH)D levels.
Why It Was Studied
Vitamin D (VD) deficiency in pregnancy and the neonatal period has impacts on childhood outcomes.
Maternal VD sufficiency is crucial for sufficiency in the neonate, though the effect of early versus late pregnancy 25-hydroxy-vitamin D (25(OH)D) levels on neonatal levels is unknown.
Who Took Part
The abstract describes 881 women taking part.
The age groups tagged for this paper are teenagers, young adults and adults, women only.
A total of 881 pregnant women at high risk of having offspring asthma were randomized to receive VD supplementation or placebo.
How the Study Was Run
In design terms this was a randomized, double-blind and placebo-controlled study.
The women were allocated by chance, so the Vitamin D, K2, Magnesium and Zinc group and the comparison group should start out alike.
As a double-blind Vitamin D, K2, Magnesium and Zinc study, the assignments were hidden from both participants and investigators until the end.
The comparison arm used a placebo, so changes seen with Vitamin D, K2, Magnesium and Zinc could be set against what happens without it.
Serum samples were collected from mothers in early and late pregnancy and from offspring cord blood at birth. 25(OH)D levels were assayed by CLIA in all maternal and offspring samples and by LC-MS/MS in all offspring samples and a subset of 200 maternal third trimester samples.
What Was Measured
Vitamin D (VD) deficiency in pregnancy and the neonatal period has impacts on childhood outcomes.
Maternal VD sufficiency is crucial for sufficiency in the neonate, though the effect of early versus late pregnancy 25-hydroxy-vitamin D (25(OH)D) levels on neonatal levels is unknown.
The subject headings attached to it are Biomarkers, Fetal Blood, Immunoassay, Prognosis, Vitamin D and Vitamin D Deficiency.
Author keywords: 25-hydroxy-vitamin D, neonatal and pregnancy.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc in 881 women.
With several hundred people or more, it is a fairly large study for this kind of research.
Results are reported in around 6 sentences of the abstract; we leave them to the paper itself rather than summarise them.
The publication is from 2020 (The Journal of clinical endocrinology and metabolism), a journal based in United States.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.